Cargando…

A breast cancer prediction model incorporating familial and personal risk factors

Detalles Bibliográficos
Autor principal:	Cuzick, Jack
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326689/ http://dx.doi.org/10.1186/1897-4287-10-S2-A29

Ejemplares similares

Selecting women for breast cancer chemoprevention and what agents should be used
por: Cuzick, J
Publicado: (2012)

Validation study of risk prediction models for female relatives of Australian women with breast cancer
por: MacInnis, R, et al.
Publicado: (2012)

A novel personal cooling system (PCS) incorporated with phase change materials (PCMs) and ventilation fans
por: Lu, Yehu, et al.
Publicado: (2015)

Chronic inflammation, C-reactive protein, and breast health: future directions to predict, prevent, personalize and inspire consumerism in the mitigation of breast cancer
por: Covington, CY, et al.
Publicado: (2009)

Common genomic variants associated with breast cancer predict the risk of second primary breast cancer diagnosis
por: Sawyer, S, et al.
Publicado: (2012)

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients
por: Thompson, ER, et al.
Publicado: (2012)

Cancer predisposing BARD1 mutations in breast-ovarian cancer families
por: Ratajska, Magdalena, et al.
Publicado: (2012)

Arsenic (As) and breast cancer risk
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Iron and breast cancer risk
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Zinc and breast cancer risk
por: Kaczmarek, Katarzyna, et al.
Publicado: (2012)

Incorporation of MRI-AIF information for improved kinetic modelling of dynamic PET data
por: Sari, Hasan, et al.
Publicado: (2014)

Risk Models for Breast Cancer and Their Validation
por: Brentnall, Adam R., et al.
Publicado: (2020)

From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine
por: Younesi, Erfan, et al.
Publicado: (2014)

Familial risk and diagnosis of colorectal cancer in young individuals
por: Elsakov, Pavel
Publicado: (2015)

Multi-parameter systematic strategy opinion that predicts, prevents, and personalized treats a cancer
por: Zhan, Xianquan, et al.
Publicado: (2014)

Folic acid and breast cancer risk
por: Durda, Katarzyna, et al.
Publicado: (2012)

Selenium (Se) and breast cancer risk
por: Jaworska - Bieniek, Katarzyna, et al.
Publicado: (2012)

Genetic insights into breast cancer risk
por: Wong-Brown, Michelle, et al.
Publicado: (2015)

kConFab: a unique Australasian research initiative for familial breast cancer
por: Sambrook, J
Publicado: (2000)

BRCA1 mutation analysis in breast and ovarian cancer families from Greece
por: Konstantopoulou, I, et al.
Publicado: (2000)

Estrogen receptor transcription and transactivation: ErbB family of receptors in breast cancer
por: Hynes, NE, et al.
Publicado: (2001)

The spectrum of mutations in families with breast and ovarian cancer from the region of Saxony, Germany
por: Tomys, Michalina, et al.
Publicado: (2015)

GWAS markers in diagnostics of breast cancer risk
por: Jakubowska, Anna
Publicado: (2012)

The expression of the EGFR family members in breast carcinomas
por: Suo, Z, et al.
Publicado: (2000)

Heterocyclic amines (HCAS) and risk of breast cancer
por: Sinha, R, et al.
Publicado: (2001)

Assessing risk for breast cancer
por: Cuzick, Jack
Publicado: (2008)

Pitfalls and perspectives in cancer genomes NGS studies: implications for predictive, preventive and personalized medicine (PPPM)
por: Rovigatti, Ugo
Publicado: (2014)

The role of human photosynthesis in predictive, preventive and personalized medicine
por: Suchkov, Sergey, et al.
Publicado: (2014)

An audit of families with unreported or misreported cancers verified through a population-based cancer registry: implications for providing cancer risk assessment and management advice by a Familial Cancer Centre
por: Kentwell, M, et al.
Publicado: (2012)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

p16(INK4A) as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy
por: Geisler, S, et al.
Publicado: (2000)

Mutation detection in familial and sporadic breast cancers by denaturing high-performance liquid chromatography (DHPLC)
por: Betz, B, et al.
Publicado: (2001)

Constitutional alterations of 9p23-24 in independent BRCA2 breast cancer families
por: Schwab, M, et al.
Publicado: (2000)

Rapid test for detection of high risk of breast cancer
por: Durda, K, et al.
Publicado: (2012)

Selenium (Se) and the risk of breast, ovarian and prostate cancers
por: Jaworska, Katarzyna, et al.
Publicado: (2012)

Risk-reducing surgery for breast and ovarian cancer risks - where are we now?
por: Hallowell, N, et al.
Publicado: (2012)

New international education project in predictive, preventive and personalized medicine
por: Safonicheva, Olga
Publicado: (2014)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
por: Bielecka, Helena, et al.
Publicado: (2012)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
por: Bielecka, Helena, et al.
Publicado: (2012)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sjnkcajeotjrqdjm3d418s7bq1